Completed
Topics
This workshop examined the impact of and investment in the use of genetic and genomic data in drug development. The goal of the workshop was to discuss how genomic and genetic data have been and will be used in the drug development process to improve aspects such as target identification, clinical trial design, pharmacogenomics approaches, biomarker development and understanding disease biology.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People